stockportfolio.pro
EHC vs MDGL: Which Stock Is the Better Buy?
Encompass Health Corporation and Madrigal Pharmaceuticals, Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
AI verdict — EHC vs MDGL, read from the filings
The stronger business, the cheaper stock, and the risks — synthesised from both companies’ SEC filings, every figure computed not guessed. Not investment advice.
| Encompass Health Corporation (EHC) | Madrigal Pharmaceuticals, Inc. (MDGL) | |
|---|---|---|
| Market cap | $10.1B | $11.0B |
| Revenue (latest FY) | $5.94B | $958.40M |
| Net income (latest FY) | $566.20M | $-288.28M |
| Revenue growth (5y CAGR) | 10.7% | — |
| Net margin | 9.5% | -30.1% |
| Return on equity | 23.2% | -47.8% |
| P/E ratio | 17.5 | — |
| Dividend yield | 0.7% | — |
| Profitable years (of last 10) | 10 | 0 |
| Positive free cash flow | Yes | No |
See the full EHC vs MDGL breakdown
Both companies across 19 years of income statement, balance sheet and cash flow — with ratios, health checks and Ask, the SEC-grounded research assistant. Free, no account needed.
Open EHC's full financials → Open MDGL's full financials →More comparisons
Frequently asked questions
Which is bigger, EHC or MDGL?
Madrigal Pharmaceuticals, Inc. is larger by market capitalization — $11.0B versus $10.1B.
Which grows faster, EHC or MDGL?
Five-year growth data is not available for both companies.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.
Keep exploring
EHC fundamentals → · MDGL fundamentals → · All 1,500+ companies → · Free screener →